

Video Player is loading.
10 seconds
Playback speed
SOHO Italy 2022 on the Phase 2/3 HARBOR Study: BLU-263 in Patients With Indolent Systemic Mastocytosis and Monoclonal Mast Cell Activation Syndrome
By
SOHO 4th Italian Conference
FEATURING
Cristina Papayannidis
By
SOHO 4th Italian Conference
FEATURING
Cristina Papayannidis
Comments 0
Login to view comments.
Click here to Login